India is emerging as a leading player in the world's search for a "variant-proof" corn emerging variants of coronaviruses and future epidemics. If things go to plan, the pharma industry thinks an India-developed pan-coronavirus vaccine may be available in the next two to three years.
Out of the nine projects awarded by the Coalition for Epidemic Preparedness Innovations (CEPI), a partnership between public, private and philanthropic organisations to develop vaccines against future epidemics, two are from India. The Bharat Biotech, University of Sydney, and ExcellGene consortium is the latest to be awarded $19.3 million by CEPI under its $200-million programme launched in March 2021 to advance the development of vaccines that would provide broad protection against the Sars-CoV-2 variants and also other beta coronaviruses. In February, Panacea Biotec, along with the public sector institute Translational Health Science and Technology Institute (THSTI), had won funding support of $12.5 million for a broad-protection vaccine.
Richard Hatchett, chief executive officer, CEPI, had acknowledged then that Indian scientists and industry have played a central role in the global fight against Covid-19.
Hatchett had warned that the Sars-CoV-2 that causes Covid-19 will not be the last coronavirus to infect humans, and there is nothing to stop the next one being even more deadly or contagious. "It's, therefore, vital for global health security that we invest now in research to develop vaccines that are broadly protective against variants of SARSCoV-2 and other coronaviruses before they emerge," he had said.
هذه القصة مأخوذة من طبعة May 20, 2022 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة May 20, 2022 من Business Standard.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 8500 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Breweries stir up barrels with mercury rising
Firms ramp up production, diversify offerings on record summer sales forecast Bengaluru,
Spice row: Norms for pesticide residue stringent, says gov
AKSHARA SRIVASTAVA & SANKET KOUL New Delhi, 5 May India has some of the most stringent norms for pesticide residues limit in food items, the government asserted on Sunday, amid reports that the regulator permits higher pesticide residues limit in herbs and spices.
Committed to theaterisation of military: Rajnath
The theaterisation process in the military is making progress as consensus is emerging among the three services on the ambitious initiative, Defence Minister Rajnath Singh (pictured) said in first clear remarks reflecting forward movement in the mega reform initiative.
THE EXPENDABLES
Is the COO position becoming redundant?
Small is beautiful, but not always
For most SFBs, being a small bank is part of their journey, not the destination
A case for making RBI regulations plain, simple
The April bulletin of the Reserve Bank of India (RBI) has an interestin 'Gauging Linguistic Complexity of on Regulatory Communication'.
Sequence of returns' big impact on final corpus
Prem invests 1 lakh per annum for 30 years, earning 12 per cent per annum for the first 15 years and 6 per cent for the next 15 years.
Protecting streedhan: Maintain inventory, store in woman's locker
The husband's family should also document all gifts to avoid false allegations
M&M's growth engines roar to life, launches to drive gains
SUCCESS MILEAGE: Investor confidence accelerates with growth focus
'Elections stoke volatility but don't alter market dynamics'
With less than a month remaining until the declaration of results for the 18th Lok Sabha elections, the markets are witnessing a spike in volatility. While the victory for the incumbent Bharatiya Janata Party government has largely been factored into market expectations, the uncertainty surrounding the allocation of seats is stirring some apprehension among investors. NIKET SHAH, the newly appointed chief investment officer (CIO) at Motilal Oswal Mutual Fund (MF), suggests that if the ruling coalition fails to secure a substantial majority, it could exacerbate short-term market volatility. Shah, who oversees assets valued at ₹46,000 crore, shares with Abhishek Kumar via email that valuations remain reasonable, and the potential for higher earnings growth is bolstering the ascent of small and midcap stocks. Edited excerpts:
